Annual Working Capital
$49.62 M
-$38.81 M-43.89%
December 31, 2024
Summary
- As of March 10, 2025, VYNE annual working capital is $49.62 million, with the most recent change of -$38.81 million (-43.89%) on December 31, 2024.
- During the last 3 years, VYNE annual working capital has risen by +$4.84 million (+10.81%).
- VYNE annual working capital is now -61.82% below its all-time high of $129.96 million, reached on December 31, 2018.
Performance
VYNE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$49.62 M
-$11.26 M-18.49%
December 1, 2024
Summary
- As of March 10, 2025, VYNE quarterly working capital is $49.62 million, with the most recent change of -$11.26 million (-18.49%) on December 1, 2024.
- Over the past year, VYNE quarterly working capital has stayed the same.
- VYNE quarterly working capital is now -67.18% below its all-time high of $151.19 million, reached on March 31, 2018.
Performance
VYNE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
VYNE Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.9% | 0.0% |
| 3 y3 years | +10.8% | 0.0% |
| 5 y5 years | -26.7% | 0.0% |
VYNE Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.9% | +71.5% | -43.9% | +348.5% |
| 5 y | 5-year | -43.9% | +71.5% | -59.2% | +348.5% |
| alltime | all time | -61.8% | +79.5% | -67.2% | +348.5% |
VYNE Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $49.62 M(-43.9%) | - |
| Dec 2024 | - | $49.62 M(-18.5%) |
| Sep 2024 | - | $60.87 M(-15.5%) |
| Jun 2024 | - | $72.02 M(-13.5%) |
| Mar 2024 | - | $83.29 M(-5.8%) |
| Dec 2023 | $88.42 M(+205.7%) | $88.42 M(+699.4%) |
| Sep 2023 | - | $11.06 M(-33.3%) |
| Jun 2023 | - | $16.59 M(-35.0%) |
| Mar 2023 | - | $25.50 M(-11.8%) |
| Dec 2022 | $28.93 M(-35.4%) | $28.93 M(-22.2%) |
| Sep 2022 | - | $37.21 M(-17.5%) |
| Jun 2022 | - | $45.09 M(-13.4%) |
| Mar 2022 | - | $52.07 M(+16.3%) |
| Dec 2021 | $44.78 M | $44.78 M(-18.8%) |
| Sep 2021 | - | $55.13 M(-22.1%) |
| Jun 2021 | - | $70.81 M(-41.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $121.57 M(+85.6%) |
| Dec 2020 | $65.49 M(-3.2%) | $65.49 M(-12.6%) |
| Sep 2020 | - | $74.97 M(-21.1%) |
| Jun 2020 | - | $95.06 M(+127.1%) |
| Mar 2020 | - | $41.85 M(-38.1%) |
| Dec 2019 | $67.67 M(-47.9%) | $67.67 M(-19.4%) |
| Sep 2019 | - | $83.98 M(-17.0%) |
| Jun 2019 | - | $101.22 M(-11.7%) |
| Mar 2019 | - | $114.59 M(-11.8%) |
| Dec 2018 | $129.96 M(+131.9%) | $129.96 M(-11.2%) |
| Sep 2018 | - | $146.41 M(-0.8%) |
| Jun 2018 | - | $147.51 M(-2.4%) |
| Mar 2018 | - | $151.19 M(+169.8%) |
| Dec 2017 | $56.04 M(+102.8%) | $56.04 M(-18.3%) |
| Sep 2017 | - | $68.56 M(+148.1%) |
| Dec 2016 | $27.64 M(-35.9%) | $27.64 M |
| Dec 2015 | $43.12 M | - |
FAQ
- What is VYNE Therapeutics annual working capital?
- What is the all time high annual working capital for VYNE Therapeutics?
- What is VYNE Therapeutics annual working capital year-on-year change?
- What is VYNE Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for VYNE Therapeutics?
- What is VYNE Therapeutics quarterly working capital year-on-year change?
What is VYNE Therapeutics annual working capital?
The current annual working capital of VYNE is $49.62 M
What is the all time high annual working capital for VYNE Therapeutics?
VYNE Therapeutics all-time high annual working capital is $129.96 M
What is VYNE Therapeutics annual working capital year-on-year change?
Over the past year, VYNE annual working capital has changed by -$38.81 M (-43.89%)
What is VYNE Therapeutics quarterly working capital?
The current quarterly working capital of VYNE is $49.62 M
What is the all time high quarterly working capital for VYNE Therapeutics?
VYNE Therapeutics all-time high quarterly working capital is $151.19 M
What is VYNE Therapeutics quarterly working capital year-on-year change?
Over the past year, VYNE quarterly working capital has changed by $0.00 (0.00%)